Thrive Capital Management (Pennsylvania) Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
|
+$4.58M |
| 2 |
iShares US Treasury Bond ETF
GOVT
|
+$3.1M |
| 3 |
iShares Core Moderate Allocation ETF
AOM
|
+$2.95M |
| 4 |
iShares Core Dividend Growth ETF
DGRO
|
+$2.53M |
| 5 |
iShares 0-5 Year High Yield Corporate Bond ETF
SHYG
|
+$2.25M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Short Maturity Bond ETF
NEAR
|
+$1.82M |
| 2 |
Qualcomm
QCOM
|
+$996K |
| 3 |
CVS Health
CVS
|
+$983K |
| 4 |
iShares Ultra Short Duration Bond Active ETF
ICSH
|
+$955K |
| 5 |
PepsiCo
PEP
|
+$951K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 4.51% |
| 2 | Healthcare | 3.28% |
| 3 | Consumer Staples | 1.92% |
| 4 | Utilities | 1.58% |
| 5 | Financials | 1.49% |
Similar funds
Thrive Capital Management (Pennsylvania)'s Q4 2021 Portfolio in Review
As of Q4 2021, Thrive Capital Management (Pennsylvania) held 128 positions worth $154M, up 13% from $135M the previous quarter. Its ten largest holdings account for 50% of the portfolio.
Thrive Capital Management (Pennsylvania) deployed $9.94M of net new capital in Q4 2021, opening 21 new positions and adding to 27 existing holdings. Its largest new stake was VanEck Semiconductor ETF: 12,506 shares worth $1.93M.
By sector, the portfolio is most concentrated in Technology at 4.5% of assets, down from 8.6% a quarter earlier, followed by Healthcare and Consumer Staples.
On the sell side, the largest reduction was iShares Short Maturity Bond ETF, an estimated $1.82M trimmed.
- Thrive Capital Management (Pennsylvania)'s largest Q4 2021 buy was VanEck Semiconductor ETF: 12,506 shares worth $1.93M.
- Thrive Capital Management (Pennsylvania) added most to State Street SPDR Portfolio S&P 500 Growth ETF in Q4 2021, an estimated $4.58M increase.
- Thrive Capital Management (Pennsylvania)'s biggest Q4 2021 reduction was iShares Short Maturity Bond ETF, cutting an estimated $1.82M.
- Thrive Capital Management (Pennsylvania) fully exited First Trust NYSE Arca Biotechnology Index Fund in Q4 2021, selling an estimated $713K.
- Thrive Capital Management (Pennsylvania)'s ten largest holdings make up 50% of its $154M portfolio in Q4 2021.
- Thrive Capital Management (Pennsylvania) opened 21 new positions and closed 27 in Q4 2021.
- Thrive Capital Management (Pennsylvania)'s portfolio value rose 13% quarter-over-quarter to $154M.
Based on Thrive Capital Management (Pennsylvania)'s 13F filing for Q4 2021, filed 9 Feb 2022.